Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Wide series of cell adhesion inhibitors in the Merck pipeline

Jan. 21, 2000

Synthesis, use of series of PDE4 inhibitors reported by Merck

Jan. 21, 2000

Byk Gulden patents new PDE4 inhibitors

Jan. 19, 2000

IL-5 receptor antagonists discovered at Structural Bioinformatics

Jan. 19, 2000

EpiGenesis and Chiesi enter license and development agreement for asthma therapy

Jan. 18, 2000

Aryl pyridinyl thiazoles from Novartis useful for inflammatory or obstructive airways diseases

Jan. 18, 2000

Patent and orphan drug status obtained for Inhale's alpha1-proteinase inhibitor

Jan. 18, 2000

European Commission approves new indication for AstraZeneca antiasthmatic

Jan. 17, 2000

Respiratory disease collaboration ended by mutual agreement by Millennium and AstraZeneca

Jan. 13, 2000

Agents for cough in development at Nortran as alternatives to codeine

Jan. 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...